Topic:

Emerging Markets

Latest Headlines

Latest Headlines

Glaxo plants a flag in Singapore with CEO Witty on hand

GlaxoSmithKline planted its flag in Singapore to build on a close relationship with the government of the wealthy city-state where CEO Andrew Witty worked and lived earlier in his career with the U.K. drugmaker.

Bharat's $1 rotavirus vaccine rolls out in India to challenge GSK, Merck

Back in 2011, Indian company Bharat Biotech pledged to offer its rotavirus prospect at a price that undercut even discounted vaccines from GlaxoSmithKline and Merck. Now, it's ready to make good on its promise.

China's Mindray jumps on acquisition rumor involving state-owned investment firm

The share price of China's Mindray Medical rose 16% last week on the New York Stock Exchange amid rumors that it will be taken over by private equity firms, including the country's state-owned investment company.

GSK sacks 100-plus China workers for misconduct in wake of bribery scandal

GlaxoSmithKline is breaking out the broom once again to clean up its act in China. It's dismissed more than 100 employees there for misconduct in part of what it calls a "zero tolerance" approach--but the fired workers aren't taking their dismissal lying down.

Aspen eyes more overseas buys after recent deals pay off

South Africa-based Aspen Pharmacare is looking for more overseas products and companies to snap up. CEO Stephen Saad tells Reuters that he's "looking the hardest" in Asia.

Jordan's MS Pharma gets $30M to expand manufacturing there

Western drugmakers finding their way into the Middle East and North Africa are being met by some domestic companies expanding operations in an effort to take on this competition. Among those is MS Pharma, which is now expanding manufacturing in Jordan with a loan from the European Bank for Reconstruction and Development.

Siemens Healthcare accused of faking contracts in China

Medical device companies have been jittery about being accused of corruption in China ever since the infamous crackdown on GlaxoSmithKline in 2013, which resulted in a $490 million fine for bribery.

Indian diagnostics company Thyrocare aims for $100M IPO

Indian diagnostics company Thyrocare, which touts itself as "the world's largest thyroid testing laboratory," is planning an IPO on the Indian stock market by the end of June with hopes of raising $85 to $100 million.

Bharat, Serum Institute ramp up production of their swine flu vaccines

Two Indian vaccinemakers are ramping up production of their swine flu vaccines, to replace stocks that were destroyed recently after they expired.

Takeda places vaccines unit in Singapore to push for global growth

Last September, Takeda announced it would be putting vaccines into their own specialty business unit to "accelerate the globalization" of the business. And now, it's positioning the unit geographically to do the same.